Knock-in mice bearing the Ile26Ala BRCA1 RING domain mutation (which compromises its E3 ligase activity but retains the ability to form heterodimer with BARD1) did not display any overt developmental defects or increased predisposition for developing tumours [168]. This evidence concerns the gene BARD1 and neoplasm.